Name | CHF-6001 |
---|---|
Synonyms |
(1S)-1-[3-(Cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-(3,5-dichloro-1-oxido-4-pyridinyl)ethyl 3-(cyclopropylmethoxy)-4-[(methylsulfonyl)amino]benzoate
CHF-6001 0984EU6E2F Benzoic acid, 3-(cyclopropylmethoxy)-4-[(methylsulfonyl)amino]-, (1S)-1-[3-(cyclopropylmethoxy)-4-(difluoromethoxy)phenyl]-2-(3,5-dichloro-1-oxido-4-pyridinyl)ethyl ester |
Description | Tanimilast (CHF-6001) is a novel highly potent and selective phosphodiesterase 4 inhibitor(IC50=0.026 ± 0.006 nM) with robust anti-inflammatory activity and suitable for topical pulmonary administration.Tanimilast is used for the research of obstructive lung diseases[1]. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 811.5±75.0 °C at 760 mmHg |
Molecular Formula | C30H30Cl2F2N2O8S |
Molecular Weight | 687.54 |
Flash Point | 444.6±37.1 °C |
Exact Mass | 686.106812 |
LogP | 4.43 |
Vapour Pressure | 0.0±2.9 mmHg at 25°C |
Index of Refraction | 1.631 |